U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06894745) titled 'PET [89Zr]DFO-starPEG in Solid Tumors' on March 18.
Brief Summary: This is a first-in-human, pilot study of the novel PET-imaging radiotracer [89Zr]DFO-starPEG. The study is designed to obtain preliminary data to support future development of this agent as an imaging surrogate to visualize enhanced permeability and retention (EPR)-mediated tracer uptake before administration of EPR-based nanomedicines.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Solid Tumor
Solid Carcinoma
Soft Tissue Lesion
Intervention:
DRUG: 89-zr-dfo-star polyethylene glycol (StarPEG)
Given intravenously (IV)
PROCEDURE: Whole Body P...